Vanessa's Comment:

This is one of the more promising investigative treatments currently in trials for recurrent GBM. We did a webinar with Dr. Marc Hedrick on this treatment last year, where he shared some of the Phase 1 results and preliminary data from the Phase 2 trial. The full Phase 1 results are now published and available here. Information on the Phase 2 trial, which is currently recruiting, can be found here


Posted on: 03/10/2025

Plus Therapeutics Announces Peer-Reviewed Publication in Nature Communications Highlighting Promising Phase 1 Results for Rhenium (186Re) Obisbemeda in Glioblastoma

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!